|
Volumn 111, Issue 6 Pt 1, 2003, Pages
|
Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
PRESERVATIVE;
THIOMERSAL;
ARTICLE;
BLOOD;
CHEMISTRY;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DISEASE TRANSMISSION;
DRUG CONTRAINDICATION;
FEMALE;
HEALTH CARE PLANNING;
HEPATITIS B;
HOSPITAL;
HUMAN;
INFANT;
MASS SCREENING;
MULTICENTER STUDY;
NEWBORN;
NEWBORN DISEASE;
PREGNANCY;
PREGNANCY COMPLICATION;
PREVENTIVE HEALTH SERVICE;
STATISTICS;
UNITED STATES;
VIROLOGY;
FEMALE;
HEALTH PLANNING GUIDELINES;
HEPATITIS B;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VACCINES;
HOSPITALS, URBAN;
HUMANS;
IMMUNIZATION PROGRAMS;
INFANT;
INFANT, NEWBORN;
INFANT, NEWBORN, DISEASES;
MASS SCREENING;
MICHIGAN;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PRESERVATIVES, PHARMACEUTICAL;
THIMEROSAL;
MLCS;
MLOWN;
|
EID: 0038312152
PISSN: None
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.111.6.e645 Document Type: Article |
Times cited : (19)
|
References (0)
|